tiprankstipranks
Advertisement
Advertisement

TSE:MRVL Stock Latest News

Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
Company AnnouncementsMarvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
1d ago
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
PremiumCompany Announcements
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
6d ago
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
PremiumCompany Announcements
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
7d ago
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
PremiumCompany Announcements
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
15d ago
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
PremiumCompany Announcements
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
20d ago
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
PremiumCompany AnnouncementsMarvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
27d ago
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
Premium
Company Announcements
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
1M ago
Marvel Biosciences Grants Deferred Share Units to Independent Directors
Premium
Company Announcements
Marvel Biosciences Grants Deferred Share Units to Independent Directors
2M ago
Marvel Biosciences Wins NRC IRAP Support for Pediatric Liquid Form of Lead Neurodrug
PremiumCompany Announcements
Marvel Biosciences Wins NRC IRAP Support for Pediatric Liquid Form of Lead Neurodrug
2M ago
Marvel Biosciences Wins Key Japanese Patent for Lead Neurology Drug MB-204
PremiumCompany Announcements
Marvel Biosciences Wins Key Japanese Patent for Lead Neurology Drug MB-204
2M ago
Marvel Biosciences Issues Deferred Share Units to Directors
PremiumCompany Announcements
Marvel Biosciences Issues Deferred Share Units to Directors
5M ago
Marvel Biosciences Accelerates Warrant Expiry Amid Strong Shareholder Confidence
PremiumCompany Announcements
Marvel Biosciences Accelerates Warrant Expiry Amid Strong Shareholder Confidence
6M ago
Marvel Biosciences Secures Chinese Patent for Lead Drug Candidate MB-204
PremiumCompany AnnouncementsMarvel Biosciences Secures Chinese Patent for Lead Drug Candidate MB-204
8M ago
Marvel Biosciences Grants Deferred Share Units to Directors
Premium
Company Announcements
Marvel Biosciences Grants Deferred Share Units to Directors
8M ago
Marvel Biosciences Completes $1 Million Private Placement to Advance Neurological Research
Premium
Company Announcements
Marvel Biosciences Completes $1 Million Private Placement to Advance Neurological Research
11M ago
Marvel Biosciences Closes Second Tranche of Private Placement
PremiumCompany Announcements
Marvel Biosciences Closes Second Tranche of Private Placement
12M ago
Marvel Biosciences’ MB-204 Shows Promising Results in Rett Syndrome Study
PremiumCompany Announcements
Marvel Biosciences’ MB-204 Shows Promising Results in Rett Syndrome Study
12M ago
Marvel Biosciences to Present MB-204 Research at IRSF Meeting
PremiumCompany Announcements
Marvel Biosciences to Present MB-204 Research at IRSF Meeting
12M ago
Marvel Biosciences to Present Alzheimer’s Research at 2025 International Conference
PremiumCompany Announcements
Marvel Biosciences to Present Alzheimer’s Research at 2025 International Conference
1y ago
Marvel Biosciences Secures $1 Million in Private Placement
PremiumCompany AnnouncementsMarvel Biosciences Secures $1 Million in Private Placement
1y ago
Marvel Biosciences Pursues Orphan Drug Designation for Rett Syndrome Treatment
Premium
Company Announcements
Marvel Biosciences Pursues Orphan Drug Designation for Rett Syndrome Treatment
1y ago
Marvel Biosciences’ MB-204 Shows Promise in Rett Syndrome Study
Premium
Company Announcements
Marvel Biosciences’ MB-204 Shows Promise in Rett Syndrome Study
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >